This content is machine translated 25th EADV Congress in Vienna Progress in melanoma treatment: more success with combination therapies Just a few years ago, metastatic melanoma was rapidly fatal – but today the disease responds frequently and long-term to new drug therapies. Experts reported on advances in melanoma therapy…
View Post 12 min This content is machine translated Non-small cell lung cancer Individualized, palliative first-line therapy is possible Therapy for non-small cell lung cancer is individualized and based on tumor stage, histology, and predictive molecular markers, taking into account the patient profile. To maximize the therapeutic outcome for…
